ANGIODYNAMICS INC: Point72 Asset Management, L.P. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Point72 Asset Management amended its Schedule 13G filing for AngioDynamics Inc., updating its stake disclosure with the SEC under accession number 0000919574-26-008102. The filing, submitted under Point72's CIK 0000919574, revises the firm's previously reported beneficial ownership position in the medical device maker. Schedule 13G amendments are typically filed when a passive investor's ownership crosses the 5% threshold or when previously reported holdings change materially. The update gives investors a fresh look at Point72's position in AngioDynamics, a company whose shares are sensitive to shifts in institutional ownership. What to watch next is whether the amended filing reflects an increase or reduction in Point72's stake and whether other large holders follow with their own 13G updates.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
AngioDynamics Inc, Point72 Asset Management, L.P.